Recombinant Human LILRB1/CD85j/ILT2 His-tag Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 8989-T2
Key Product Details
Source
HEK293
Accession #
Structure / Form
Monomer
Conjugate
Unconjugated
Applications
Bioactivity
Product Specifications
Source
Human embryonic kidney cell, HEK293-derived human LILRB1/CD85j/ILT2 protein
Human LILRB1 (Gly24-His458) Accession # Q8NHL6 |
HHHHHH |
N-terminus | C-terminus |
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Gly24
Predicted Molecular Mass
48 kDa
SDS-PAGE
65-82 kDa, reducing conditions
Activity
Measured by its binding ability in a functional ELISA.
When Recombinant Human LILRB1/CD85j/ILT2 is coated at 2 µg/mL, Recombinant Human Angiopoietin-like Protein 7/ANGPTL7 (Catalog # 914-AN) binds with a typical ED50 of 0.02-0.2 μg/mL.
When Recombinant Human LILRB1/CD85j/ILT2 is coated at 2 µg/mL, Recombinant Human Angiopoietin-like Protein 7/ANGPTL7 (Catalog # 914-AN) binds with a typical ED50 of 0.02-0.2 μg/mL.
Reviewed Applications
Read 2 reviews rated 4.5 using 8989-T2 in the following applications:
Scientific Data Images for Recombinant Human LILRB1/CD85j/ILT2 His-tag Protein, CF
When Recombinant Human LILRB1/CD85j/ILT2 His-tag (Catalog # 8989-T2) is coated at 2 µg/mL, Recombinant Human Angiopoietin-like Protein 7/ANGPTL7 (914-AN) binds with a typical ED50 of 0.02-0.2 μg/mL.
Formulation, Preparation and Storage
8989-T2
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution |
Reconstitute at 100 μg/mL in PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: LILRB1/CD85j/ILT2
in-house testing indicates that LILRB1 also binds to Angiopoietin-like 7. Ligation of LILRB1 inhibits the antigen induced proliferation and activation of CD8+ T cells, CD4+ T cells, NK cells, and gamma delta T cells (3, 4, 11-13). On dendritic cells, ligation inhibits the production of IL-10, IL-12p70, and TGF-beta and protects from Fas-mediated apoptosis (7).
References
- Thomas, R. et al. (2010) Clin. Rev. Allergy Immunol. 38:159.
- Samaridis, J. and M. Colonna (1997) Eur. J. Immunol. 27:660.
- Colonna, M. et al. (1997) J. Exp. Med. 186:1809.
- Harly, C. et al. (2011) Blood 117:2864.
- Cosman, D. et al. (1997) Immunity 7:273.
- Young, N.T. et al. (2001) J. Immunol. 166:3933.
- Young, N.T. et al. (2008) Blood 111:3090.
- Lepin, E.J.M. et al. (2000) Eur. J. Immunol. 30:3552.
- Shiroishi, M. et al. (2003) Proc. Natl. Acad. Sci. USA 100:8856.
- Allen, R.L. et al. (2001) J. Immunol. 167:5543.
- Ince, M.N. et al. (2004) Immunology 112:531.
- Saverino, D. et al. (2000) J. Immunol. 165:3742.
- Saverino, D. et al. (2002) J. Immunol. 168:207.
Long Name
Leukocyte Immunoglobulin-like Receptor, Subfamily A (with TM domain), Member 1
Alternate Names
CD85j, ILT2, LIR1, MIR7
Entrez Gene IDs
10859 (Human)
Gene Symbol
LILRB1
UniProt
Additional LILRB1/CD85j/ILT2 Products
Product Documents for Recombinant Human LILRB1/CD85j/ILT2 His-tag Protein, CF
Product Specific Notices for Recombinant Human LILRB1/CD85j/ILT2 His-tag Protein, CF
For research use only
Loading...
Loading...
Loading...